144 related articles for article (PubMed ID: 1646492)
1. [Laboratory parameters for the control of the course of therapy of canine Cushing's syndrome].
Reusch C; Hähnle B
Tierarztl Prax; 1991 Feb; 19(1):102-6. PubMed ID: 1646492
[TBL] [Abstract][Full Text] [Related]
2. o,p'-DDD (mitotane) treatment of canine pituitary-dependent hyperadrenocorticism.
Peterson ME
J Am Vet Med Assoc; 1983 Mar; 182(5):527-8. PubMed ID: 6300010
[No Abstract] [Full Text] [Related]
3. [Experiences with Lysodren therapy of Cushing's syndrome in the dog (1)].
Opitz M; Lettow E; Loppnow H; Grevel V
Tierarztl Prax; 1983; 11(3):369-84. PubMed ID: 6636131
[No Abstract] [Full Text] [Related]
4. [Experiences with Lysodren treatment of Cushing's syndrome in dogs].
Opitz M; Lettow E; Loppnow H; Grevel V
Tierarztl Prax; 1983; 11(4):507-20. PubMed ID: 6658774
[No Abstract] [Full Text] [Related]
5. [Formal pathogenesis, average age and breed distribution in the comparison of 61 Lysodren-treated and 36 untreated cases of canine hyperadrenocorticism which were dissected in the years 1975 to 1991 at the Institute for Veterinary Pathology of the Free University of Berlin].
Nothelfer HB; Weinhold K
Berl Munch Tierarztl Wochenschr; 1992 Sep; 105(9):305-11. PubMed ID: 1417721
[TBL] [Abstract][Full Text] [Related]
6. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
Angles JM; Feldman EC; Nelson RW; Feldman MS
J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
[TBL] [Abstract][Full Text] [Related]
7. Diurnal ACTH and plasma cortisol variations in healthy dogs and in those with pituitary-dependent Cushing's syndrome before and after treatment with retinoic acid.
Castillo VA; Cabrera Blatter MF; Gómez NV; Sinatra V; Gallelli MF; Ghersevich MC
Res Vet Sci; 2009 Apr; 86(2):223-9. PubMed ID: 18692856
[TBL] [Abstract][Full Text] [Related]
8. Problems associated with medical therapy of canine hyperadrenocorticism.
Nichols R
Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism.
Feldman EC
J Am Vet Med Assoc; 1983 Mar; 182(5):506-10. PubMed ID: 6300008
[No Abstract] [Full Text] [Related]
10. Diseases of the adrenal cortex of dogs and cats.
Kaufman J
Mod Vet Pract; 1984 Jun; 65(6):429-34. PubMed ID: 6330521
[TBL] [Abstract][Full Text] [Related]
11. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
[TBL] [Abstract][Full Text] [Related]
12. Pituitary tumor size, neurologic signs, and relation to endocrine test results in dogs with pituitary-dependent hyperadrenocorticism: 43 cases (1980-1990).
Kipperman BS; Feldman EC; Dybdal NO; Nelson RW
J Am Vet Med Assoc; 1992 Sep; 201(5):762-7. PubMed ID: 1328121
[TBL] [Abstract][Full Text] [Related]
13. Hypoadrenocorticism following therapy with o,p-DDD for hyperadrenocorticism in four dogs.
Willard MD; Schall WD; Nachreiner RF; Shelton DG
J Am Vet Med Assoc; 1982 Mar; 180(6):638-41. PubMed ID: 7068503
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD).
Schechter RD; Stabenfeldt GH; Gribble DH; Ling GV
J Am Vet Med Assoc; 1973 Apr; 162(8):629-39. PubMed ID: 4697358
[No Abstract] [Full Text] [Related]
15. [Case presentation in small animal medicine].
Gfeller G; Reusch C
Schweiz Arch Tierheilkd; 1998; 140(9):375-9. PubMed ID: 9757786
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of canine Cushing's syndrome based on multiple steroid analysis and dexamethasone turnover kinetics.
Lothrop CD; Oliver JW
Am J Vet Res; 1984 Nov; 45(11):2304-9. PubMed ID: 6098199
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of canine pituitary-dependent hyperadrenocorticism (Cushing's disease).
Peterson ME
Vet Clin North Am Small Anim Pract; 2001 Sep; 31(5):1005-14, viii. PubMed ID: 11570123
[TBL] [Abstract][Full Text] [Related]
18. Plasma cortisol response to exogenous ACTH in 22 dogs with hyperadrenocorticism caused by adrenocortical neoplasia.
Peterson ME; Gilbertson SR; Drucker WD
J Am Vet Med Assoc; 1982 Mar; 180(5):542-4. PubMed ID: 6277837
[TBL] [Abstract][Full Text] [Related]
19. Hyperadrenocorticism in the dog: canine Cushing's syndrome.
Owens JM; Drucker WD
Vet Clin North Am; 1977 Aug; 7(3):583-602. PubMed ID: 198937
[No Abstract] [Full Text] [Related]
20. Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane.
Frank LA; Hnilica KA; Oliver JW
Vet Dermatol; 2004 Oct; 15(5):278-84. PubMed ID: 15500479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
